Chen-Hung Chiu

Chang Gung University

Papers

1

Total Citations

56

H-Index

1

About

Dr. Chen-Hung Chiu is a pioneering thoracic surgeon whose research centers on minimally invasive esophageal cancer surgery, with a particular focus on comparing robotic-assisted and video-assisted thoracoscopic approaches. His landmark work, the REVATE trial—a multicenter randomized clinical trial published in 2024 with 56 citations—directly addresses the critical challenge of recurrent laryngeal nerve injury during esophagectomy for esophageal squamous cell carcinoma. This injury, which can cause vocal cord palsy and elevate pulmonary complication risks, has long been a major surgical hurdle. Dr. Chiu’s trial provides rigorous evidence comparing robotic and video-assisted techniques, offering insights into how to improve patient safety and outcomes in this technically demanding procedure. His contributions are vital for surgeons seeking to reduce nerve damage and enhance recovery in esophageal cancer patients. With his work shaping clinical guidelines and sparking further investigation, Dr. Chiu stands out as a leader in advancing surgical precision and quality of life for those battling this aggressive disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)
56 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Chang Gung University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago